$VXRT no denying manipulation ; a company loses 2% or so on news of P2 doesn’t make sense. One would assume this would make the company more valuable having the only COVID mucosal virus blocking Vaccine pill with clinical data to back it. A pipeline consisting of a Norovirus pill and a flu pill that has data showing it’s better than the leading injectable.
2
13
13 Likes